- Filed
- May 6, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Apr 29, 2025 | 80.96M sh |
| Current Liabilities | Q3 2025 · Mar 31, 2025 | $297.32M |
| Current Liabilities | Q3 2025 · Jun 30, 2024 | $300.65M |
| Total Liabilities | Q3 2025 · Mar 31, 2025 | $321.21M |
| Total Liabilities | Q3 2025 · Jun 30, 2024 | $329.76M |
| Current Assets | Q3 2025 · Mar 31, 2025 | $432.98M |
| Current Assets | Q3 2025 · Jun 30, 2024 | $342.65M |
| Total Assets | Q3 2025 · Mar 31, 2025 | $813.51M |
| Total Assets | Q3 2025 · Jun 30, 2024 | $733M |
| Cash And Equivalents | Q3 2025 · Jun 30, 2024 | $208.37M |
| Cash And Equivalents | Q3 2025 · Mar 31, 2024 | $187.43M |
| Shares Diluted | Q3 2025 · Mar 31, 2024 | 72.63M sh |
| Shares Diluted | Q3 2025 · Mar 31, 2024 | 70.69M sh |
| Capex | Q3 2025 · Mar 31, 2024 | $1.73M |
| Operating Cash Flow | Q3 2025 · Mar 31, 2024 | $40.15M |
| Stockholders Equity | Q3 2025 · Mar 31, 2024 | $385.97M |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | $371.66M |
| Stockholders Equity | Q3 2025 · Jun 30, 2023 | $341.21M |
| Eps Diluted | Q3 2025 · Mar 31, 2024 | −$0.09 |
| Eps Diluted | Q3 2025 · Mar 31, 2024 | −$0.44 |
| Eps Basic | Q3 2025 · Mar 31, 2024 | −$0.09 |
| Eps Basic | Q3 2025 · Mar 31, 2024 | −$0.44 |
| Sga Expense | Q3 2025 · Mar 31, 2024 | $24.93M |
| Sga Expense | Q3 2025 · Mar 31, 2024 | $66.98M |
| Rd Expense | Q3 2025 · Mar 31, 2024 | $27.32M |
| Rd Expense | Q3 2025 · Mar 31, 2024 | $83.8M |
| Net Income | Q3 2025 · Mar 31, 2024 | −$6.89M |
| Net Income | Q3 2025 · Mar 31, 2024 | −$31.42M |
| Operating Income | Q3 2025 · Mar 31, 2024 | −$7.45M |
| Operating Income | Q3 2025 · Mar 31, 2024 | −$32.49M |
| Gross Profit | Q3 2025 · Mar 31, 2024 | $80.06M |
| Gross Profit | Q3 2025 · Mar 31, 2024 | $223.22M |
| Cost Of Revenue | Q3 2025 · Mar 31, 2024 | $30.58M |
| Cost Of Revenue | Q3 2025 · Mar 31, 2024 | $92.92M |
| Revenue | Q3 2025 · Mar 31, 2024 | $110.64M |
| Revenue | Q3 2025 · Mar 31, 2024 | $316.15M |